March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
- IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
- PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
- NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
- COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
- TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS
(([email protected];;))
- Forums
- ASX - By Stock
- IMU
- News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 1854997 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 382882 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 1854997 | 0.052 |
39 | 5099678 | 0.051 |
52 | 4172179 | 0.050 |
17 | 2263068 | 0.049 |
20 | 996329 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 382882 | 4 |
0.054 | 3593651 | 7 |
0.055 | 1701991 | 16 |
0.056 | 2970606 | 12 |
0.057 | 803139 | 8 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |